Vedantham honored for innovation in interventional radiology
Recognized for advances in image-guided therapies for venous blood clots
Suresh Vedantham, MD, was recognized as a Leader in Innovation for his advances in image-guided therapies for venous blood clots, and their complications. His work in refining new treatments and in leading clinical trials has influenced clinical guidelines for these conditions.
Suresh Vedantham, MD, a professor of radiology and of surgery at Washington University School of Medicine in St. Louis, has been awarded the 2024 Leader in Innovation Award by the Society of Interventional Radiology Foundation. Vedantham was recognized for his advances in image-guided therapies for venous blood clots, known as venous thromboembolism (VTE), and their complications.
Vedantham’s work in refining new treatments and in leading clinical trials has influenced clinical guidelines for VTE and post-thrombotic syndrome, which can cause lifelong pain or disability in patients who have experienced VTE. He leads national, multisite trials funded by the National Institutes of Health (NIH) that are focused on the use of optimal catheter therapies for patients with post-thrombotic syndrome and pulmonary embolism, including the Chronic Venous Thrombosis: Relief with Adjunctive Catheter Based Therapy (C-TRACT) trial. He is director of the Trial-CARE clinical trial support service at the School of Medicine and an assistant dean for clinical research.
The award acknowledges Vedantham’s approach to clinical research and interdisciplinary leadership. His success in leading large-scale NIH-funded projects has created a model for interventional radiologists and others to follow in their own research.
